Lamotrigine (Lamictal IR) for the treatment of bipolar disorder

Bibliography

• Calabrese JR, Huffman RF, White RL, Lamotrigine in the acute treatment of bipolar depression: results of five double-blind, placebo-controlled clinical trials. Bipolar Disord 2008;10:323-33
   PubMed Web of Science ®Google Scholar
• Calabrese JR, Bowden CL, Sachs GS, A. Double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. J Clin Psychiatry 1999;60:79-88
   PubMed Web of Science ®Google Scholar
• Geddes JR, Calabrese JR, Goodwin GM. Lamotrigine for treatment of bipolar depression: independent meta-analysis and meta-regression of individual patient data from five randomised trials. Br J Psychiatry 2009;194:4-9
   PubMed Web of Science ®Google Scholar
• Brown EB, McElroy S, Keck PE, A 7-week, randomized, double-blind trial of olanzapine/fluoxetine combination versus lamotrigine in the treatment of bipolar I depression. J Clin Psychiat 2006;67:1025-33
   PubMed Web of Science ®Google Scholar
• van der Loos ML, Mulder PG, Hartong EG, Efficacy and safety of lamotrigine as add-on treatment to lithium in bipolar depression: a multicenter, double-blind, placebo-controlled trial. J Clin Psychiat 2009;70:223-31
   PubMed Web of Science ®Google Scholar
• van der Loos MLM, Mulder PG, Hartong EG, Long-term outcome of bipolar depressed patients receiving lamotrigine as add-on to lithium with possibility of the addition of paroxetine in nonresponders: a randomized, placebo-controlled trial with a novel design. Bipolar Disord 2011;13:111-17
   PubMedGoogle Scholar
• Nierenberg AA, Ostacher MJ, Calabrese JR, Treatment-resistant bipolar depression: a STEP-BD equipoise randomized effectiveness trial of antidepressant augmentation with lamotrigine, inositol, or risperidone. Am J Psychiat 2006;163:210-16
   PubMed Web of Science ®Google Scholar
• Schaffer A, Zuker P, Levitt AJ. A Randomized, double-blind pilot trial comparing lamotrigine versus citalopram for the treatment of bipolar depression. J Affect Disord 2006;96:95-9
   PubMedGoogle Scholar
• Nolen WA, Kupka RW, Hellemann G, Tranylcypromine vs. lamotrigine in the treatment of refractory bipolar depression: a failed but clinically useful study. Acta Psychiatr Scand 2007;115:360-5
   PubMed Web of Science ®Google Scholar
• Barbee JG, Thompson TR, Jamhour NJ, A double-blind placebo-controlled trial of lamotrigine as an antidepressant augmentation agent in treatment-refractory unipolar depression. J Clin Psychiat 2011;72:1405-12
   PubMed Web of Science ®Google Scholar
• Normann C, Hummel B, Scharer LO. Lamotrigine as adjunct to paroxetine in acute depression: a placebo-controlled, double blind study. J Clin Psychiat 2002;63:337-44
   PubMed Web of Science ®Google Scholar
• Barbosa L, Berk M, Vorster M. A double-blind, randomized, placebo-controlled trial of augmentation with lamotrigine or placebo in patients concomitantly treated with fluoxetine for resistant major depressive episodes. J Clin Psychiat 2003;64:403-7
   PubMed Web of Science ®Google Scholar
• Calabrese JR, Suppes T, Bowden CL, A double-blind placebo-controlled prophylaxis study of lamotrigine in rapid cycling bipolar disorder. J Clin Psychiat 2000;61:841-50
   PubMed Web of Science ®Google Scholar
• Goldsmith DR, Wagstaff AJ, Ibbotson T, Lamotrigine: a review of its use in bipolar disorder. Drugs 2003;63:2029-50
   PubMed Web of Science ®Google Scholar
• Calabrese JR, Bowden CL, Sachs G, A Placebo-Controlled 18-Month Trial of Lamotrigine and Lithium Maintenance Treatment in Recently Depresed Patients With Bipolar I Disorder. J Clin Psychiat 2003;64:1013-24
   PubMed Web of Science ®Google Scholar
• Bowden CL, Calabrese JR, Sachs G, A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder. Arch Gen Psychiatry 2003;60:392-400
   PubMed Web of Science ®Google Scholar
• Licht RW, Nielsen JN, Gram LF, Lamotrigine versus lithium as maintenance treatment in bipolar I disorder: an open, randomized effectiveness study mimicking clinical practice. The 6th trial of the Danish University Antidepressant Group (DUAG-6). Bipolar Disord 2010;12:483-93
   PubMed Web of Science ®Google Scholar
• Bowden CL, Tohen M, Mintz J, Development of Novel Integrative Multistate Measures of Efficacy, Tolerability and Functional Status in Maintenance Clinical Trials for Bipolar Disorder. Annual Meeting of the ACNP Kona; Hawaii; 2011
   Google Scholar
• Bowden CL, Singh V, Weisler R, Lamotrigine vs. lamotrigine plus divalproex in randomized, placebo-controlled maintenance treatment for bipolar depression. Acta Psychiatr Scand 2012;1-9
   PubMedGoogle Scholar
• Goldberg JF, Perlis RH, Bowden CL, Manic symptoms during depressive episodes in 1, 380 patients with bipolar disorder: findings from the STEP-BD. Am J Psychiat 2009;166:173-81
   PubMed Web of Science ®Google Scholar
• Perlis RH, Ostacher MJ, Goldberg JF, Transition to mania during treatment of bipolar depression. Neuropsychopharmacology 2010;35:2545-52
   PubMed Web of Science ®Google Scholar
• Severus WE, Lipkovich IA, Licht RW, In search of optimal lithium levels and olanzapine doses in the long-term treatment of bipolar I disorder. A post-hoc analysis of the maintenance study by Tohen. Eur Psychiatry 2005;25:443-9
   Google Scholar
• Keck PE Jr, Bowden CL, Meinhold JM, Relationship between serum valproate and lithium levels and efficacy and tolerability in bipolar maintenance therapy. Int J Psychiatry Clin Pract 2005;9:271-7
   PubMed Web of Science ®Google Scholar
• Ghaemi NS, Shirzadi AA, Filkowski MM. Publication bias and the pharmaceutical industry: the case of lamotrigine in bipolar disorder. Medscape J Med 2008;10:211
   PubMedGoogle Scholar
• van der Loos MLM, Calabrese JR, Nolen WA, Muzina DJ. Pharmacological profile and clinical utility of lamotrigine in mood disorders. In: Akiskal HS, Tohen M, editors. Bipolar psychopharmacotherapy. 2nd edition. Wiley Blackwell; West Sussex, UK; 2012. p. 45-60
   Google Scholar
• Mitchell PB, Hadzi-Pavlovic D, Evoniuk G, Factor analysis in bipolar depression and response to lamotrigine. submitted for publication 2012
   Google Scholar